Background Flavonoid intake modifies the composition of the gut microbiome, which
contributes to the metabolism of flavonoids. Few studies have examined the contribution of …

Background: Polyphenol consumption is implicated in gut microbiome composition and
improved metabolic outcomes, but it is unclear whether the effect is independent of dietary …

Obesity is characterized by low‐grade inflammation and a number of metabolic disorders.
Distal gut microbes' content (microbiota) is not yet fully understood but evidence shows that …

At a population level, there is growing evidence of the beneficial effects of dietary flavonoids
on health. However, there is extensive heterogeneity in the response to increased intake …

Anthocyanins are a type of natural pigment that has numerous health benefits. In recent
years, the interaction of anthocyanins with gastrointestinal (GI) microbiota has been …

Background. Anthocyanins and prebiotics impact overall health and wellness, likely through
modulation of the microbiota and the intestinal ecosystem. Objectives. An 8-week open-label …

Anthocyanins have a great potential for human health, as a sub-group of phenolic
compounds. Interactions of anthocyanin involved in digestion and thus in obesity consist of …

Background: Metabolic associated fatty liver disease (MAFLD) formerly known as non-
alcoholic fatty liver disease (NAFLD) was the most common chronic liver disease. Flavonoid …

Cardiometabolic disease (CMD) is a leading cause of death worldwide and encompasses
the inflammatory metabolic disorders of obesity, type 2 diabetes mellitus, nonalcoholic fatty …

Background: Although dietary flavonoid intake has been associated with less weight gain,
there are limited data on its impact on fat mass, and to our knowledge, the contribution of …